share_log

argenx SE | 6-K: argenx Announces FDA Acceptance of Supplemental Biologics License Application

SEC announcement ·  Feb 20 06:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more